表纸
市场调查报告书
商品编码
1037915

支气管内超音波切片检查的全球市场(2021年~2028年)

Global Endobronchial Ultrasound Biopsy Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

支气管内超音波检验,是为了诊断胸部的淋巴节肿的肺癌和感染疾病,其他疾病的微创效果高的检验方法。由于EBUS使用支气管镜的工具进行,这个检验不会在胸部上有外科性的刀伤。

EBUS设备的技术进步,消费者喜好微创手术,结核等呼吸系统疾病增加,肺癌症患者数增加等成为市场成长的促进因素。但,预计支气管内超音波切片检查相关的并发症妨碍市场成长。

本报告提供全球支气管内超音波切片检查市场的相关调查,市场规模,机会和影响,成长及阻碍因素,COVID-19的影响,各产品类型、应用、终端用户、地区的市场分析,竞争情形,主要企业的简介等资讯。

目录

第1章 全球支气管内超音波切片检查市场调查手法和范围

  • 调查手法
  • 调查的目的和调查范围

第2章 全球支气管内超音波切片检查市场-市场定义和概要

第3章 全球支气管内超音波切片检查市场-摘要整理

  • 各产品类型的市场明细
  • 各应用领域的市场明细
  • 各终端用户的市场明细
  • 各地区的市场明细

第4章 全球支气管内超音波切片检查市场-市场动态

  • 影响市场的要素
    • 成长要素
    • 阻碍因素
    • 市场机会
    • 影响分析

第5章 全球支气管内超音波切片检查市场-产业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 法规分析
  • 偿付分析
  • 未满足需求

第6章 全球支气管内超音波切片检查市场-COVID-19分析

  • Covid-19市场的影响分析
    • COVID-19前的市场情境
    • COVID-19目前市场情境
    • COVID-19之后或未来情境
  • Covid-19的价格动态
  • 需求与供给的频谱
  • 大流行时的市场相关的政府举措
  • 制造商策略性举措
  • 结论

第7章 全球支气管内超音波切片检查市场-各产品类型

  • 简介
    • 各产品类型的市场规模分析,及与前一年同期比较成长分析(%)
    • 各产品类型的市场魅力指数
  • 经支气管细针抽吸
    • 简介
    • 市场规模分析,百万美元,2019年~2028年及与前一年同期比较成长分析(%),2020年~2028年
  • 切片穿刺针
  • 切片钳
  • 其他

第8章 全球支气管内超音波切片检查市场-各应用领域

  • 简介
    • 市场规模分析,及与前一年同期比较成长分析(%),各应用领域
    • 各应用领域的市场魅力指数
  • 肺癌症的诊断
    • 简介
    • 市场规模分析,百万美元,2019年~2028年及与前一年同期比较成长分析(%),2020年~2028年
  • 肺感染疾病的诊断
  • 其他

第9章 全球支气管内超音波切片检查市场-各终端用户

  • 简介
    • 各终端用户的市场规模分析,及与前一年同期比较成长分析(%)
    • 各终端用户的市场魅力指数
  • 医院
    • 简介
    • 市场规模分析,百万美元,2019年~2028年及与前一年同期比较成长分析(%),2020年~2028年
  • 诊断研究所
  • 其他

第10章 全球支气管内超音波切片检查市场-各地区

  • 简介
    • 市场规模分析,百万美元,2019年~2028年及与前一年同期比较成长分析(%),2020年~2028年,各地区
    • 各地区的市场魅力指数
  • 北美
    • 简介
    • 主要地区具体动态
    • 各产品类型的市场规模分析,及与前一年同期比较成长分析(%)
    • 各应用领域的市场规模分析,及与前一年同期比较成长分析(%)
    • 各终端用户的市场规模分析,及与前一年同期比较成长分析(%)
    • 各国市场规模分析,及与前一年同期比较成长分析(%)
  • 欧洲
    • 简介
    • 主要地区具体动态
    • 各产品类型的市场规模分析,及与前一年同期比较成长分析(%)
    • 各应用领域的市场规模分析,及与前一年同期比较成长分析(%)
    • 各终端用户的市场规模分析,及与前一年同期比较成长分析(%)
    • 各国市场规模分析,及与前一年同期比较成长分析(%)
  • 南美
    • 简介
    • 主要地区具体动态
    • 各产品类型的市场规模分析,及与前一年同期比较成长分析(%)
    • 各应用领域的市场规模分析,及与前一年同期比较成长分析(%)
    • 各终端用户的市场规模分析,及与前一年同期比较成长分析(%)
    • 各国市场规模分析,及与前一年同期比较成长分析(%)
  • 亚太地区
    • 简介
    • 主要地区具体动态
    • 各产品类型的市场规模分析,及与前一年同期比较成长分析(%)
    • 各应用领域的市场规模分析,及与前一年同期比较成长分析(%)
    • 各终端用户的市场规模分析,及与前一年同期比较成长分析(%)
    • 各国市场规模分析,及与前一年同期比较成长分析(%)
  • 中东、非洲
    • 简介
    • 主要地区具体动态
    • 各产品类型的市场规模分析,及与前一年同期比较成长分析(%)
    • 各应用领域的市场规模分析,及与前一年同期比较成长分析(%)
    • 各终端用户的市场规模分析,及与前一年同期比较成长分析(%)

第11章 全球支气管内超音波切片检查市场-竞争情形

  • 主要趋势与策略
  • 企业占有率分析
  • 产品的基准

第12章 全球支气管内超音波切片检查市场-企业简介概要

  • Olympus Corporation
    • 公司概要
    • 产品系列、概要
    • 主要的焦点
    • 财务概要
  • Medtronic plc
  • CLINODEVICE
  • CONMED Corporation
  • Medi-Globe Corporation
  • Boston Scientific Corporation
  • Veran Medical Technologies
  • Simbionix USA Corporation
  • FUJIFILM Corporation
  • Cook Group Incorporated

第13章 全球支气管内超音波切片检查市场-DataM

  • 附录
  • 关于本公司、服务
  • 咨询方式
目录
Product Code: DMMI4308

Market Overview

The global endobronchial ultrasound biopsy market size was valued at US$ XX million in 2020 and is estimated to reach US$ XX million by 2028,growing at a high CAGR of XX % during the forecast period (2021-2028).

Endobronchial ultrasound is a minimally invasive but highly effective procedure for diagnosing lung cancer, infections, and other diseases with enlarged lymph nodes in the chest.An EBUS uses a bronchoscope tool to do this, and no surgical cuts will be made in the chest for this procedure.

Market Dynamics

The factors driving the market growth are technological advancements in EBUS devices, consumer preference for minimally invasive surgeries, the rising prevalence of respiratory diseases such as tuberculosis, and the high number of people who have lung cancer are all contributing factors.

Technological advancements in EBUS devices is expected to drive the global endobronchial ultrasound biopsy market in the forecast period

Over the last decades, technological advancements have enabled pulmonologists to perform endobronchial ultrasounds (EBUS). The multilayered structure of the tracheobronchial wall can be analyzed better with an EBUS mini-probe than with any other imaging modality. It can be used to biopsy peripheral lesions instead of fluoroscopic guided biopsy. For mediastinal lymph node staging of lung cancer, EBUS-transbronchial needle aspiration has proven useful.Other than EBUS RP, new techniques have emerged in the last decade to help guide and biopsy PPLs(peripheral pulmonary lesions)through the tracheobronchial tree during bronchoscopy. Virtual bronchoscopy (VB) and electromagnetic navigation bronchoscopy (ENB) can generate a virtual image for biopsy. ENB provides approach directions in real-time. When ENB or VB are used for biopsy, the diagnostic yield is comparable to EBUS RP guidance biopsy. However, the diagnostic yield increases significantly when two combined methods, such as EBUS RP + ENB or EBUS RP + VB. Another tool for improving diagnostic accuracy is ultrathin bronchoscopy. It has a 3.0 mm diameter and includes a working channel.

The other method which is expected to drive the market is the ROSE of EBUS-TBNA. It is a well-established tool for improving procedure yield. Rapid on-site evaluation in conjunction with TBNA reduces the cytopathology laboratory's workload by significantly reducing pulmonologists' total number of slides compared to samples without ROSE. Most importantly, ROSE results in better patient care. When ROSE is used, different clinical trials and large series have reported lower complication rates.

For example, on February 25, 2021, Rela Hospital in Chennai launched EBUS (Endobronchial Ultrasound) Bronchoscopy. It is one of the city's few that has this technology. The hospital carries out EBUS bronchoscopy procedures and FNA biopsy via EBUS by ROSE method.

Complications related to endobronchial ultrasound biopsy is expected to hamper the market growth

Sedation complications include hypoxemia and hypotension, whereas bronchoscopy complications include bronchospasm, laryngospasm, nausea, vomiting, bleeding due to scope trauma, cardiac arrhythmias, and vasovagal syncope. Pneumothorax and bleeding are two complications associated with EBUS-TBNA.Furthermore, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a sophisticated technique that requires expertise and experience to implement effectively. Evidence-based procedures for training pulmonologists in the area of EBUS-TBNA are required; however, there are currently no such accepted or standard techniques for assessing EBUS technical skills and competencies, which would hamper the market's growth. And the high cost of these medical devices and a lack of proper reimbursement policies in emerging economies may potentially restrain the market.

COVID-19 Impact Analysis

Bronchoscopy is widely regarded as an aerosol-generating procedure (AGP). This, combined with the prioritization of preserving limited personal protective equipment (PPE) stock, resulted in unanimous agreement that non-urgent bronchoscopy be postponed until the coronavirus disease 2019 (COVID19) pandemic had passed.Bronchoscopy is used in patients with suspected or confirmed COVID-19 infection, according to current guidelines. Patients continue to present with symptoms and findings unrelated to COVID-19 infection throughout the pandemic but due to suspected lung cancer. Bronchoscopy remains a potentially harmful procedure in these patients. Because of the medical field's focus on treating COVID-19, funding for R&D activities related to endobronchial ultrasound biopsy has been reduced. It has been neglected, resulting in a negative impact on the endobronchial ultrasound biopsy market.

The higher prevalence of the SARS-CoV-2 virus in people with lung disorders, on the other hand, is associated with higher mortality and morbidity rates, which is expected to drive up market demand for endobronchial ultrasound biopsy devices.

Segment Analysis

The transbronchial aspirational needles segment is expected to dominate the global endobronchial ultrasound biopsy market

Transbronchial needle aspiration (TBNA) is a technique for obtaining cellular material by passing a needle through the bronchial wall. It is used to obtain tissue from lesions of the lung or hilar/mediastinal system that are close to the endobronchial tree.TBNA allows for the minimally invasive diagnosis and staging of pulmonary, hilar, and mediastinal lesions (particularly lung cancer) and evaluating these areas for non-malignant pathology such as sarcoidosis. Despite these benefits, TBNA has previously been an underutilized technique, a trend that may change as trainees gain more experience with the procedure.The recent advancement of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) reignited interest and confidence in TBNA. Conventional transbronchial needle aspiration refers to TBNA without EBUS (C-TBNA).

For instance, the role of Boston Scientific company's eXcelon Transbronchial Aspiration Needle is designed to aspiration bronchial tree lesions in the carinal, paratracheal, and hilar regions where biopsy forceps cannot obtain a submucosal sample.Technological advances and widespread use of these needles in gastroenterology and pulmonology are expected to drive the market in the forecast period.

Geographical Analysis

North America region accounted for the largest market share in the global endobronchial ultrasound biopsy market

An increase in lung cancer and chronic respiratory disease, product launches and FDA approval in this region is expected to drive the market growth.

According to The American Cancer Society in the United States, in 2021, there will be approximately 235,760 new cases of lung cancer each year (119,100 in men and 116,660 in women). Lung cancer claimed the lives of approximately 131,880 people (69,410 in men and 62,470 in women). Lung cancer primarily affects the elderly. Most of the people diagnosed with lung cancer are 65 or older. Only a small number of people diagnosed are under 45. It is the leading cause of cancer death in both men and women, accounting for nearly 25% of all cancer deaths.Bronchoscopy with EBUS (endobronchial ultrasound) is a procedure used to diagnose various types of lung disorders, such as inflammation, infections, or cancer. And with the increasing incidence of lung cancer, the market is expected to grow in the forecast period.

On February 20, 2019, The US Food and Drug Administration (FDA) approved Intuitive Surgical Inc.'s Ion endoluminal system for minimally invasive biopsy in the peripheral lung.

Competitive Landscape

The global endobronchial ultrasound biopsy market is moderately competitive with major key players' FDA approvals, company megers and product launches.

The key players in the global endobronchial ultrasound biopsy market are Medtronic plc, Olympus Corporation, Clinodevice, CONMED Corporation, Medi-Globe Corporation, Boston Scientific Corporation, Veran Medical Technologies, Simbionix USA Corporation, FUJIFILM Corporation and Cook Group Incorporated.

Olympus Corporation

  • Overview: Olympus Corporation is a Japanese optics and reprography product manufacturer. On October 12, 1919, Olympus was founded, initially specializing in microscopes and thermometers. Olympus controls roughly 70% of the global endoscope market.
  • Product Portfolio: The company's BF-UC190F, when used with the versatile Olympus ViziShot EBUS-TBNA needle portfolio, enables physicians to access and sample difficult-to-reach targets such as lymph nodes in the mediastinum (4L) and hilum (10R). Powerful Scope Angulation, Compact Distal Tip, Steeper Puncture Angle, and Enhanced Endoscopic View are key design features of the BF-UC190F that enable improved access and sampling.
  • Key Development: On May 12, 2021, The BF-UC190F endobronchial ultrasound (EBUS) bronchoscope cleared FDA approval for market launch, the newest addition to Olympus' robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

Why Purchase the Report?

  • Visualize the composition of the global endobronchial ultrasound biopsy market segmentation by product type, by application and end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in global endobronchial ultrasound biopsy market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global endobronchial ultrasound biopsy market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global endobronchial ultrasound biopsy market report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Endobronchial Ultrasound Biopsy Market- By Product Type

  • Transbronchial Aspiration Needles
  • Biopsy Needles
  • Biopsy Forceps
  • Other

Global Endobronchial Ultrasound Biopsy Market- By Application

  • Lung Cancer Diagnosis
  • Lung Infection Diagnosis
  • Other

Global Endobronchial Ultrasound Biopsy Market- By End-User

  • Hospitals
  • Diagnostics Laboratories
  • Other

Global Endobronchial Ultrasound Biopsy Market- By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Global Endobronchial Ultrasound Biopsy Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Endobronchial Ultrasound Biopsy Market- Market Definition and Overview

3. Global Endobronchial Ultrasound Biopsy Market- Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Endobronchial Ultrasound Biopsy Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancements in EBUS devices diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Complications related to endobronchial ultrasound biopsy
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Endobronchial Ultrasound Biopsy Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Endobronchial Ultrasound Biopsy Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Endobronchial Ultrasound Biopsy Market- By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Transbronchial Aspiration Needles*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Biopsy Needles
  • 7.4. Biopsy Forceps
  • 7.5. Other

8. Global Endobronchial Ultrasound Biopsy Market- By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Lung Cancer Diagnosis
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Lung Infection Diagnosis
  • 8.4. Other

9. Global Endobronchial Ultrasound Biopsy Market- By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Diagnostics Laboratories
  • 9.4. Other

10. Global Endobronchial Ultrasound Biopsy Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.5.1. U.S.
      • 10.2.5.2. Canada
      • 10.2.5.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.5.1. Brazil
      • 10.4.5.2. Argentina
      • 10.4.5.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.5.1. China
      • 10.5.5.2. India
      • 10.5.5.3. Japan
      • 10.5.5.4. Australia
      • 10.5.5.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Global Endobronchial Ultrasound Biopsy Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Endobronchial Ultrasound Biopsy Market- Company Profiles

  • 12.1. Olympus Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Medtronic plc
  • 12.3. CLINODEVICE
  • 12.4. CONMED Corporation
  • 12.5. Medi-Globe Corporation
  • 12.6. Boston Scientific Corporation
  • 12.7. Veran Medical Technologies
  • 12.8. Simbionix USA Corporation
  • 12.9. FUJIFILM Corporation
  • 12.10. Cook Group Incorporated (*LIST NOT EXHAUSTIVE)

13. Global Endobronchial Ultrasound Biopsy Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us